About Elomatic-Pharmalab Consulting and Engineering Private Limited
Data last updated:
Elomatic-Pharmalab Consulting and Engineering Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Elomatic Oy. It operates in the procurement and construction (epc) segment of the engineering sector. It was incorporated on 27 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2004PTC149278. Its GSTIN is 27AABCE3791N1Z6 (Maharashtra).
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹5.17 Cr. It is led by directors including Vishal Umesh Shah and Umesh Purushottam Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.56 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹24.29 Lakh (net margin 1.5%) and EBITDA of ₹88.76 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 9% over five years.
As per MCA filings, the company has satisfied charges of ₹60.4 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elomatic.com.
Company details
Contact details
Elomatic-Pharmalab Consulting and Engineering Private Limited's registered office is in Thane, Maharashtra. Its website is elomatic.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressCentrum Unit No. 301 To 304 Opp. Tmc Office Next To Satkar Grande Hotel Waghle Indl, Estate, Thane, Maharashtra, India – 400604
- IndustryEngineering, Procurement & Construction (EPC), Engineering
To see the full contact details of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elomatic-Pharmalab Consulting and Engineering is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities |
To see the full business activity and turnover split of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
Financials of Elomatic-Pharmalab Consulting and Engineering Private Limited
FY 2024 filings availableElomatic-Pharmalab Consulting and Engineering Private Limited reported revenue of ₹16.56 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.29 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
Board of directors of Elomatic-Pharmalab Consulting and Engineering Private Limited
Elomatic-Pharmalab Consulting and Engineering has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Umesh Shah Also directs: Pharmalab India Private Limited. | Director | 11 Aug 2020 | 6 Years 2 Months | Current |
| Umesh Purushottam Shah | Director | 27 Oct 2004 | 22 Years 0 Months | Current |
| Mona Akerholm Daniela | Director | 21 Apr 2022 | 4 Years 6 Months | Current |
| Tom Henrik Lind | Director | 30 Jul 2024 | 2 Years 3 Months | Current |
| Tero Seppo Juhani Tuomela | Director | 30 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Elomatic-Pharmalab Consulting and Engineering Private Limited is compared with the 3 companies closest to it by revenue in the Engineering industry (Engineering Design), with the same principal business activity (architecture, engineering activities, technical testing and analysis activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neuman and Esser Compressor Application Centre Private Limited | ₹16.72 Cr (FY 2025) | -6.0% | Pune, Maharashtra, India | |||
| Lsi Engineering & Consultants Limited | ₹16.57 Cr (FY 2025) | 192.0% | Kolkata, West Bengal, India | |||
| Elomatic-Pharmalab Consulting and Engineering Private Limitedthis company | ₹16.56 Cr (FY 2025) | ₹24.29 Lakh | 1.5% | -1.0% | Thane, Maharashtra, India | |
| Whitby Wood Pritamdasani Consulting Engineers Private Limited | ₹16.35 Cr (FY 2025) | 63.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
Auditor
Elomatic-Pharmalab Consulting and Engineering Private Limited is audited by Girish Bavishi & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Girish Bavishi & Co | FY 2023 | 103204W |
Shareholding
The shareholding of Elomatic-Pharmalab Consulting and Engineering Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jun 2021 | 100455492 | Canara Bank | ₹7.4 Lakh | Satisfied | |
| 05 Mar 2014 | 10483442 | Canara Bank | ₹25 Lakh | Satisfied | |
| 17 Feb 2014 | 10481305 | Canara Bank | ₹25 Lakh | Satisfied | |
| 01 Nov 2007 | 10074841 | Canara Bank | ₹3 Lakh | Satisfied |
To see the full charge records of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Elomatic-Pharmalab Consulting and Engineering Private Limited has 1 court case on record: 1 filed by Elomatic-Pharmalab Consulting and Engineering. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed by the company against National Dairy Development Board | Disposed |
To see the full case history of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Elomatic-Pharmalab Consulting and Engineering Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 6 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Tech Visit IT Private Limited | |||
| Sumiran Automations Private Limited |
To see the full MSME payment records of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Elomatic-Pharmalab Consulting and Engineering has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
Elomatic-Pharmalab Consulting and Engineering has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCE3791N1Z6 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Elomatic-Pharmalab Consulting and Engineering Private Limited, buy the company report.
Recent activity
Elomatic-Pharmalab Consulting and Engineering Private Limited has 14 board changes on record since 2004: 5 appointments and 9 cessations. The latest: Tom Henrik Lind ceased to be Additional Director on 29 Sep 2024.
13 earlier events are in the company report.
Frequently asked questions
Elomatic-Pharmalab Consulting and Engineering is an active private limited company based in Thane, Maharashtra, India. The company works in procurement and construction (epc), within the engineering industry. It was incorporated on 27 October 2004 (22+ years old) and is registered under CIN U73100MH2004PTC149278.
Elomatic-Pharmalab Consulting and Engineering has 5 current directors:
- Vishal Umesh Shah - Director
- Umesh Purushottam Shah - Director
- Mona Akerholm Daniela - Director
- Tom Henrik Lind - Director
- Tero Seppo Juhani Tuomela - Director
The latest financial statements of Elomatic-Pharmalab Consulting and Engineering on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Elomatic-Pharmalab Consulting and Engineering is 27AABCE3791N1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Elomatic-Pharmalab Consulting and Engineering is U73100MH2004PTC149278. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elomatic-Pharmalab Consulting and Engineering has 1 court case on record: 1 filed by the company.
Elomatic-Pharmalab Consulting and Engineering was incorporated on 27 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Elomatic-Pharmalab Consulting and Engineering by revenue are Neuman and Esser Compressor Application Centre Private Limited, Lsi Engineering & Consultants Limited, Whitby Wood Pritamdasani Consulting Engineers Private Limited, all in the Engineering industry (Engineering Design), with the same principal business activity (architecture, engineering activities, technical testing and analysis activities).
Tom Henrik Lind ceased to be Additional Director on 29 Sep 2024. Tom Henrik Lind was appointed as Director on 30 Jul 2024. Mona Akerholm Daniela ceased to be Additional Director on 29 Sep 2022. Elomatic-Pharmalab Consulting and Engineering has 14 board changes on record in total.
Elomatic-Pharmalab Consulting and Engineering has 5 MSME Form 1 returns on record between 2019 and 2022, listing 6 overdue payments to 3 micro and small suppliers. The latest return was filed on 25 Sep 2023.
Elomatic-Pharmalab Consulting and Engineering can be reached through the website elomatic.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Elomatic-Pharmalab Consulting and Engineering is at Centrum Unit No. 301 To 304 Opp. Tmc Office Next To Satkar Grande Hotel Waghle Indl, Estate, Thane, Maharashtra, India – 400604.